Press Release Archive - 2011

This section contains information and press releases about us. This information should be considered accurate only as of the date prepared. You acknowledge that this information may change over time and you should not assume that the information is accurate at a later date. Antares Pharma, Inc. is not obligated to update the press releases and information contained in this section of the Company’s website.

14 Feb 2011

Receipt of NDA User Fee Waiver
READ  

08 Apr 2011

Antares Pharma Announces FDA Acceptance of Anturol
READ  

29 Mar 2011

Antares Pharma to Present at the 10th Annual Needham Healthcare Conference
READ  

14 Mar 2011

Antares Pharma Reports Fourth Quarter and Full Year 2010 Financial and Operating Results
READ  

08 Mar 2011

Antares Pharma to Present at the Roth 23rd Annual OC Growth Stock Conference
READ  

07 Mar 2011

Antares Pharma to Host Fourth Quarter and Full Year 2010 Earnings Call
READ  

01 Mar 2011

Antares Pharma to Present at the 31st Annual Cowen Health Care Conference
READ  

14 Feb 2011

Antares Pharma Announces Receipt of NDA User Fee Waiver
READ  

01 Feb 2011

Antares Pharma Announces First Rheumatoid Arthritis Patient Dosed in VIBEX™ MTX Clinical Trial
READ  

12 Jan 2011

Antares Pharma to Initiate Clinical Trial of VIBEX
READ  

03 May 2011

Antares Pharma to Host First Quarter 2011 Earnings Call
READ  

03 May 2011

Antares Pharma First Quarter Earnings Call Announcement
READ  

09 May 2011

Antares Pharma First Quarter 2011 Earnings Results
READ  

13 May 2011

Pricing Announcement
READ  

18 May 2011

Closing Announcement
READ  

09 May 2011

Antares Pharma Reports First Quarter 2011 Financial and Operating Results
READ  

12 May 2011

Antares Pharma Announces Proposed Public Offering of Common Stock
READ  

13 May 2011

Antares Pharma Announces Pricing of Public Offering of Common Stock
READ  

18 May 2011

Antares Pharma Announces Closing of Public Offering of Common Stock
READ  

11 Jul 2011

Watson and Antares Announce Exclusive License Agreement for Antares' Oxybutynin Gel Product Anturol
READ  

01 Aug 2011

Antares Pharma to Host Second Quarter 2011 Earnings Call
READ  

04 Aug 2011

Antares Pharma Announces Positive Study Results with VIBEX MTX in Rheumatoid Arthritis Patients -New Patent Application Filed
READ  

08 Aug 2011

Antares Pharma Reports Second Quarter 2011 Financial and Operating Results
READ  

04 Oct 2011

Antares Pharma Granted New U.S. Patent Covering VIBEX Injector Technology
READ  

01 Nov 2011

AIS 3Q Earnings Call Announcement
READ  

08 Nov 2011

Antares Q3 2011 Earnings
READ  

29 Nov 2011

Antares Pharma Announces Issuance of New Libigel Patent
READ  

08 Dec 2011

Antares' Oxybutynin Gel Product Approved by FDA for the Treatment of Overactive Bladder
READ  

12 Dec 2011

Antares Pharma to Present at the Oppenheimer 22nd Annual Healthcare Conference
READ  

20 Dec 2011

Antares Pharma Enters Licensing Agreement with Pfizer Consumer Healthcare
READ